SC
BMY icon

Searle & Co’s Bristol-Myers Squibb BMY Stock Holding History

Searle & Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.84M Hold
79,811
– – 1.22% 24
2025
Q4 		$4.31M Buy
79,811
+1,350
+2% +$64.9K 1.11% 26
2025
Q3 		$3.54M Sell
78,461
-5,899
-7% -$275K 0.94% 32
2025
Q2 		$3.91M Sell
84,360
-150
-0.2% -$7.36K 1.1% 30
2025
Q1 		$5.15M Hold
84,510
– – 1.47% 19
2024
Q4 		$4.78M Hold
84,510
– – 1.38% 20
2024
Q3 		$4.37M Sell
84,510
-9,836
-10% -$461K 1.09% 23
2024
Q2 		$3.92M Buy
94,346
+1,765
+2% +$79K 0.92% 25
2024
Q1 		$5.02M Sell
92,581
-11,500
-11% -$586K 1.28% 18
2023
Q4 		$5.34M Buy
104,081
+11,048
+12% +$580K 1.46% 18
2023
Q3 		$5.4M Sell
93,033
-111
-0.1% -$6.8K 1.84% 14
2023
Q2 		$5.79M Sell
93,144
-112
-0.1% -$7.51K 1.79% 13
2023
Q1 		$6.23M Hold
93,256
– – 2.04% 9
2022
Q4 		$6.71M Hold
93,256
– – 2.29% 7
2022
Q3 		$6.63M Hold
93,256
– – 2.55% 6
2022
Q2 		$7.18M Hold
93,256
– – 2.83% 5
2022
Q1 		$6.81M Buy
93,256
+100
+0.1% +$6.71K 2.51% 5
2021
Q4 		$5.81M Sell
93,156
-400
-0.4% -$23.5K 2.11% 7
2021
Q3 		$5.54M Hold
93,556
– – 2.27% 7
2021
Q2 		$6.25M Buy
93,556
+389
+0.4% +$25.4K 2.56% 4
2021
Q1 		$5.88M Hold
93,167
– – 2.62% 5
2020
Q4 		$5.78M Buy
93,167
+1,600
+2% +$98.4K 2.78% 5
2020
Q3 		$5.52M Hold
91,567
– – 3.01% 4
2020
Q2 		$5.38M Hold
91,567
– – 3.12% 3
2020
Q1 		$5.1M Hold
91,567
– – 3.62% 2
2019
Q4 		$5.88M Hold
91,567
– – 3.24% 2
2019
Q3 		$4.64M Buy
91,567
+1,834
+2% +$86.2K 2.74% 5
2019
Q2 		$4.07M Sell
89,733
-317
-0.4% -$14.8K 2.47% 7
2019
Q1 		$4.3M Sell
90,050
-548
-0.6% -$27.3K 2.68% 4
2018
Q4 		$4.71M Hold
90,598
– – 3.31% 4
2018
Q3 		$5.62M Sell
90,598
-90
-0.1% -$5.34K 3.3% 3
2018
Q2 		$5.02M Buy
90,688
+1,000
+1% +$54K 3.18% 3
2018
Q1 		$5.67M Buy
89,688
+500
+0.6% +$32.2K 3.69% 3
2017
Q4 		$5.46M Sell
89,188
-112
-0.1% -$7K 3.43% 4
2017
Q3 		$5.69M Buy
89,300
+200
+0.2% +$11.7K 3.76% 2
2017
Q2 		$4.96M Sell
89,100
-1,400
-2% -$76.2K 3.41% 4
2017
Q1 		$4.92M Buy
90,500
+100
+0.1% +$5.49K 3.45% 4
2016
Q4 		$5.28M Buy
90,400
+24,200
+37% +$1.32M 4.38% 2
2016
Q3 		$3.65M Buy
+66,200
New +$4.25M 3.18% 3
2016
Q2 		– Sell
-64,616
Closed -$4.19M – 37
2016
Q1 		$4.19M Buy
64,616
+300
+0.5% +$18.9K 3.86% 2
2015
Q4 		$4.31M Hold
64,316
– – 4.14% 2
2015
Q3 		$3.81M Buy
64,316
+200
+0.3% +$12.7K 3.91% 2
2015
Q2 		$4.27M Hold
64,116
– – 3.56% 2
2015
Q1 		$4.13M Buy
64,116
+1,166
+2% +$73K 3.56% 2
2014
Q4 		$3.71M Buy
+62,950
New +$3.55M 3.14% 4

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Searle & Co's BMY Position: Q1 2026 in Review

Searle & Co held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 79,811 shares worth $4.84M. The position accounts for 1.22% of the portfolio, ranked #24.

Searle & Co first reported a position in BMY in Q4 2014 and has held it in 45 quarters since. The position peaked at $7.18M in Q2 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Searle & Co held 79,811 shares of Bristol-Myers Squibb worth $4.84M as of Q1 2026.
  • Searle & Co left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 1.22% of Searle & Co's portfolio in Q1 2026, its #24 holding.
  • Searle & Co first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 45 quarters since.
  • Searle & Co's Bristol-Myers Squibb position peaked at $7.18M in Q2 2022.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Searle & Co's 13F filing for Q1 2026, filed 8 May 2026.